Mauriac Syndrome: A Rare Hepatic Glycogenosis in Poorly Controlled Type 1 Diabetes

Background: Hepatic glycogenosis (HG) is a complication of poorly controlled type 1 diabetes mellitus (T1DM), characterized by glycogen accumulation in hepatocytes. Mauriac syndrome (MS) is a glycogenic hepatopathy, initially described in 1930, characterized by growth failure, delayed puberty, cushi...

Full description

Bibliographic Details
Main Authors: Marta Patita, Gonçalo Nunes, António Alves de Matos, Hélder Coelho, Cristina Fonseca, Jorge Fonseca
Format: Article
Language:English
Published: Karger Publishers 2019-01-01
Series:GE: Portuguese Journal of Gastroenterology
Subjects:
Online Access:https://www.karger.com/Article/FullText/496094
_version_ 1818188049507418112
author Marta Patita
Gonçalo Nunes
António Alves de Matos
Hélder Coelho
Cristina Fonseca
Jorge Fonseca
author_facet Marta Patita
Gonçalo Nunes
António Alves de Matos
Hélder Coelho
Cristina Fonseca
Jorge Fonseca
author_sort Marta Patita
collection DOAJ
description Background: Hepatic glycogenosis (HG) is a complication of poorly controlled type 1 diabetes mellitus (T1DM), characterized by glycogen accumulation in hepatocytes. Mauriac syndrome (MS) is a glycogenic hepatopathy, initially described in 1930, characterized by growth failure, delayed puberty, cushingoid appearance, hepatomegaly with abnormal liver enzymes, and hypercholesterolemia. HG is a condition with good prognosis and fast resolution after adequate glycemic control (although it has potential for relapse), with no case of evolution to end-stage liver disease described. Case: We describe a 26-year-old female, with T1DM complicated by severe retinopathy. The patient maintained poor glycemic control since childhood, presenting glycated hemoglobin persistently higher than 10% and recurrent episodes of ketoacidosis. In adolescence, she developed hepatomegaly and fluctuating elevation of aminotransferases and triglycerides. A small, nonrepresentative hepatic biopsy suggested macrovacuolar steatosis and mild fibrosis. After 15 years of diabetes, the patient was referred for gastroenterology clinic due to chronic diarrhea and exuberant hepatomegaly. Laboratory showed persistent elevation of aminotransferases and triglycerides. Bilirubin, iron metabolism, and coagulation were normal; viral serologies and autoimmune study were negative. Upper endoscopy, ileocolonoscopy, and enteroscopy presented no lesions. Abdominal magnetic resonance imaging displayed massive hepatomegaly. Liver biopsy was repeated showing marked nuclear glycogenization, mild steatosis, and no fibrosis; electron microscopy revealed very large deposits of glycogen and pleomorphic mitochondria with an unusually dense matrix, described for the first time in this entity. The diagnosis of MS variant and diarrhea due to autonomic neuropathy were assumed. Conclusion: Currently, HG is a well-recognized disease that occurs at any age and can be present without the full spectrum of features initially described for MS. In the era of insulin therapy, this entity represents a rare complication, caused by low therapeutic compliance.
first_indexed 2024-12-11T23:20:45Z
format Article
id doaj.art-f58304d59e7849bbaca982ea91f6f315
institution Directory Open Access Journal
issn 2341-4545
2387-1954
language English
last_indexed 2024-12-11T23:20:45Z
publishDate 2019-01-01
publisher Karger Publishers
record_format Article
series GE: Portuguese Journal of Gastroenterology
spelling doaj.art-f58304d59e7849bbaca982ea91f6f3152022-12-22T00:46:22ZengKarger PublishersGE: Portuguese Journal of Gastroenterology2341-45452387-19542019-01-011510.1159/000496094496094Mauriac Syndrome: A Rare Hepatic Glycogenosis in Poorly Controlled Type 1 DiabetesMarta PatitaGonçalo NunesAntónio Alves de MatosHélder CoelhoCristina FonsecaJorge FonsecaBackground: Hepatic glycogenosis (HG) is a complication of poorly controlled type 1 diabetes mellitus (T1DM), characterized by glycogen accumulation in hepatocytes. Mauriac syndrome (MS) is a glycogenic hepatopathy, initially described in 1930, characterized by growth failure, delayed puberty, cushingoid appearance, hepatomegaly with abnormal liver enzymes, and hypercholesterolemia. HG is a condition with good prognosis and fast resolution after adequate glycemic control (although it has potential for relapse), with no case of evolution to end-stage liver disease described. Case: We describe a 26-year-old female, with T1DM complicated by severe retinopathy. The patient maintained poor glycemic control since childhood, presenting glycated hemoglobin persistently higher than 10% and recurrent episodes of ketoacidosis. In adolescence, she developed hepatomegaly and fluctuating elevation of aminotransferases and triglycerides. A small, nonrepresentative hepatic biopsy suggested macrovacuolar steatosis and mild fibrosis. After 15 years of diabetes, the patient was referred for gastroenterology clinic due to chronic diarrhea and exuberant hepatomegaly. Laboratory showed persistent elevation of aminotransferases and triglycerides. Bilirubin, iron metabolism, and coagulation were normal; viral serologies and autoimmune study were negative. Upper endoscopy, ileocolonoscopy, and enteroscopy presented no lesions. Abdominal magnetic resonance imaging displayed massive hepatomegaly. Liver biopsy was repeated showing marked nuclear glycogenization, mild steatosis, and no fibrosis; electron microscopy revealed very large deposits of glycogen and pleomorphic mitochondria with an unusually dense matrix, described for the first time in this entity. The diagnosis of MS variant and diarrhea due to autonomic neuropathy were assumed. Conclusion: Currently, HG is a well-recognized disease that occurs at any age and can be present without the full spectrum of features initially described for MS. In the era of insulin therapy, this entity represents a rare complication, caused by low therapeutic compliance.https://www.karger.com/Article/FullText/496094Type 1 diabetes mellitusHepatic glycogenosisMauriac syndromeNonalcoholic fatty liver diseaseLiver biopsy
spellingShingle Marta Patita
Gonçalo Nunes
António Alves de Matos
Hélder Coelho
Cristina Fonseca
Jorge Fonseca
Mauriac Syndrome: A Rare Hepatic Glycogenosis in Poorly Controlled Type 1 Diabetes
GE: Portuguese Journal of Gastroenterology
Type 1 diabetes mellitus
Hepatic glycogenosis
Mauriac syndrome
Nonalcoholic fatty liver disease
Liver biopsy
title Mauriac Syndrome: A Rare Hepatic Glycogenosis in Poorly Controlled Type 1 Diabetes
title_full Mauriac Syndrome: A Rare Hepatic Glycogenosis in Poorly Controlled Type 1 Diabetes
title_fullStr Mauriac Syndrome: A Rare Hepatic Glycogenosis in Poorly Controlled Type 1 Diabetes
title_full_unstemmed Mauriac Syndrome: A Rare Hepatic Glycogenosis in Poorly Controlled Type 1 Diabetes
title_short Mauriac Syndrome: A Rare Hepatic Glycogenosis in Poorly Controlled Type 1 Diabetes
title_sort mauriac syndrome a rare hepatic glycogenosis in poorly controlled type 1 diabetes
topic Type 1 diabetes mellitus
Hepatic glycogenosis
Mauriac syndrome
Nonalcoholic fatty liver disease
Liver biopsy
url https://www.karger.com/Article/FullText/496094
work_keys_str_mv AT martapatita mauriacsyndromeararehepaticglycogenosisinpoorlycontrolledtype1diabetes
AT goncalonunes mauriacsyndromeararehepaticglycogenosisinpoorlycontrolledtype1diabetes
AT antonioalvesdematos mauriacsyndromeararehepaticglycogenosisinpoorlycontrolledtype1diabetes
AT heldercoelho mauriacsyndromeararehepaticglycogenosisinpoorlycontrolledtype1diabetes
AT cristinafonseca mauriacsyndromeararehepaticglycogenosisinpoorlycontrolledtype1diabetes
AT jorgefonseca mauriacsyndromeararehepaticglycogenosisinpoorlycontrolledtype1diabetes